Showing 6-10 of 151 real-world data & outcomes research:
Panalgo and OM1 Expand Partnership to Offer OM1’s PremiOM Datasets in Panalgo’s IHD Analytics Platform

Cision June 18, 2024 Read the full press release >> Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, is announcing a new venture with partner OM1, a forefront leader in real-world evidence (RWE) insights generation, deep specialty data, and advanced AI healthcare technologies. This latest offering enables Panalgo to host OM1’s PremiOM enriched[…]

OM1, a Pioneer in Patient Registries, Launches Its Registries Center of Excellence

With a commitment to advancing innovation in patient registries from inception through implementation, the Registries CoE represents a pivotal step toward addressing critical gaps in clinical research June 13, 2024 09:00 AM Eastern Daylight Time Business Wire Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, the leader in delivering first-in-class RWE technological advancements and AI-powered[…]

OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis

Utilizing clinical data from electronic health records related to endoscopic sinus surgeries, Medtronic and OM1 found PROPEL devices result in fewer postoperative care needs in chronic rhinosinusitis patients   April 09, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and[…]

Rare Disease Detection With AI: What Tools to Trust

Dermatology Times February 20, 2024 Read the full article >> “Rare Disease Day raises awareness for the 300 million people living with rare diseases around the world and their families and carers. Relatively common symptoms can hide underlying rare diseases, leading to misdiagnosis and [delayed] treatment,” writes the Rare Disease Day organization.1 Rare Disease Day has[…]

New Treatments Bring Hope for Autoimmune Skin Conditions

Dermatology Times December 15, 2023 Stefan Weiss, MD, MBA, FAAD Read the full article >> 2023 brought exciting advances in the treatment of alopecia areata and vitiligo, autoimmune skin conditions that can significantly impact a person’s physical appearance and emotional well-being. The emergence of Janus kinase (JAK) inhibitors has shown tremendous promise as a novel[…]